Altamira Therapeutics Ltd. Adjustments For Increase Decrease In Trade And Other Payables
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Increase Decrease In Trade And Other Payables of $154.54 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2025-08-29
CHF
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|
| 2023-12-31 | -3.30M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 1.26M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 2.94M CHF 20-F/A · filed 2024-04-22 |
| 2018-12-31 | 635.52K CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | -637.18K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 632.47K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | -2.03M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|---|
| 2025-06-30 | $154.54K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $63.28K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $30.99K 6-K · filed 2025-08-29 | |
| 2023-12-31 | -$3.67M 20-F · filed 2025-04-30 | |
| 2022-12-31 | $1.32M 20-F · filed 2025-04-30 |